Holen Sie sich die Stockscreener-App
14.01
0.47%
0.065
Schlusskurs vom Vortag:
$13.94
Offen:
$13.55
24-Stunden-Volumen:
684.71K
Relative Volume:
0.61
Marktkapitalisierung:
$1.00B
Einnahmen:
$133.62M
Nettoeinkommen (Verlust:
$-177.37M
KGV:
-4.846
EPS:
-2.89
Netto-Cashflow:
$23.50M
1W Leistung:
-1.72%
1M Leistung:
+18.99%
6M Leistung:
+24.38%
1J Leistung:
-34.92%
1-Tages-Spanne:
$13.30
$14.46
1-Wochen-Bereich:
$13.30
$15.50
52-Wochen-Spanne:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Firmenname
Xencor Inc
Sektor
Branche
Telefon
626-305-5900
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Vergleichen Sie XNCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
14.04 | 994.24M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.95 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.53 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
838.08 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.12 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-29 | Hochstufung | Barclays | Underweight → Overweight |
| 2025-09-17 | Fortgesetzt | Barclays | Underweight |
| 2025-09-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-21 | Eingeleitet | William Blair | Outperform |
| 2024-12-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Bestätigt | BTIG Research | Buy |
| 2024-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Eingeleitet | BofA Securities | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-10-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-01-21 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-02-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Eingeleitet | Barclays | Underweight |
| 2020-02-25 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-01-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-11-20 | Fortgesetzt | Guggenheim | Neutral |
| 2019-08-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Eingeleitet | Mizuho | Buy |
| 2019-04-12 | Eingeleitet | Guggenheim | Buy |
| 2019-03-27 | Eingeleitet | Berenberg | Buy |
| 2019-03-15 | Eingeleitet | Raymond James | Outperform |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-03-02 | Eingeleitet | Instinet | Neutral |
| 2017-03-02 | Bestätigt | Wedbush | Outperform |
| 2016-10-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-12-22 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-05 | Bestätigt | MLV & Co | Buy |
| 2015-02-12 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-28 | Bestätigt | MLV & Co | Buy |
| 2014-07-11 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Xencor Inc Aktie (XNCR) Neueste Nachrichten
Why analysts remain bullish on Xencor Inc. stockStop Loss & Real-Time Volume Surge Alerts - newser.com
Can volume confirm reversal in Xencor Inc.2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com
Will Xencor Inc. (XE9) stock return to pre crash levelsSwing Trade & Safe Entry Point Alerts - newser.com
Is Xencor Inc. (XE9) stock undervalued historicallyPortfolio Value Summary & Expert Verified Movement Alerts - newser.com
How Xencor Inc. stock compares to growth peersWeekly Gains Report & Real-Time Volume Analysis - newser.com
Is Xencor Inc. stock gaining market shareWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
What candlestick patterns are forming on Xencor Inc.Stop Loss & Capital Protection Trade Alerts - newser.com
Xencor Inc. stock trend forecastWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
Will Xencor Inc. stock split again soonWeekly Investment Report & Verified Stock Trade Ideas - newser.com
Tick level data insight on Xencor Inc. volatilityRisk Management & Reliable Entry Point Trade Alerts - newser.com
Why institutional investors increase stakes in Xencor Inc. (XE9) stockQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
Forecasting Xencor Inc. price range with options dataInsider Selling & Verified Entry Point Signals - newser.com
What MACD and RSI say about Xencor Inc.Stock Surge & AI Based Buy and Sell Signals - newser.com
Using Python tools to backtest Xencor Inc. strategiesPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
Should you hold or exit Xencor Inc. nowEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Tools to assess Xencor Inc.’s risk profileJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Why Xencor Inc. stock remains on buy listsQuarterly Portfolio Summary & Community Consensus Trade Alerts - newser.com
Xencor Inc. stock chart pattern explainedGlobal Markets & Reliable Intraday Trade Plans - newser.com
Xencor, Inc. (XNCR) Stock forecasts - Yahoo! Finance UK
Xencor, Inc. (XNCR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Xencor, Inc. (XNCR) stock forecast and price target - Yahoo! Finance UK
Xencor upgraded to Overweight from Underweight at Barclays - MSN
Can Xencor Inc. stock continue upward trendQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Xencor Earns Relative Strength Rating Upgrade; Hits Key Benchmark - MSN
Why Xencor Inc. stock is favored by pension fundsJuly 2025 Update & Consistent Return Strategy Ideas - newser.com
Xencor Inc expected to post a loss of 69 cents a shareEarnings Preview - TradingView
How Xencor Inc. (XE9) stock benefits from digital adoptionJuly 2025 Volume & Verified High Yield Trade Plans - newser.com
Finanzdaten der Xencor Inc-Aktie (XNCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):